Glucocorticoids increase Ca2+ influx through dihydropyridine-sensitive channels linked to activation of protein kinase C in vascular smooth muscle cells. 1992

H Kato, and T Hayashi, and Y Koshino, and Y Kutsumi, and T Nakai, and S Miyabo
Third Department of Internal Medicine, Fukui Medical School, Japan.

To clarify whether protein kinase is associated with glucocorticoid-induced Ca2+ influx into vascular smooth muscle cells, we investigated the effects of protein kinase inhibitors on dexamethasone-induced 45Ca2+ uptake and dihydropyridine binding in A7r5 cells. Protein kinase C inhibitors (staurosporine and UCN-01) abolished the dexamethasone-induced 45Ca2+ uptake and [methyl-3H]PN 200-110 binding. In contrast, KT5720 and KT5823, which are more specific inhibitors of cAMP-dependent protein kinase and cGMP-dependent protein kinase, respectively, did not affect the effects of dexamethasone. Treatment with 100 nM dexamethasone for 48 hours increased protein kinase C activity in A7r5 cells. These results suggest that glucocorticoids increase Ca2+ influx through dihydropyridine-sensitive channels, linked to activation of protein kinase C in vascular smooth muscle cells.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols

Related Publications

H Kato, and T Hayashi, and Y Koshino, and Y Kutsumi, and T Nakai, and S Miyabo
March 1996, Hypertension (Dallas, Tex. : 1979),
H Kato, and T Hayashi, and Y Koshino, and Y Kutsumi, and T Nakai, and S Miyabo
February 1996, European journal of pharmacology,
H Kato, and T Hayashi, and Y Koshino, and Y Kutsumi, and T Nakai, and S Miyabo
July 1991, The American journal of physiology,
H Kato, and T Hayashi, and Y Koshino, and Y Kutsumi, and T Nakai, and S Miyabo
July 1998, The Journal of surgical research,
H Kato, and T Hayashi, and Y Koshino, and Y Kutsumi, and T Nakai, and S Miyabo
August 1989, The Journal of clinical investigation,
H Kato, and T Hayashi, and Y Koshino, and Y Kutsumi, and T Nakai, and S Miyabo
September 1999, European journal of pharmacology,
H Kato, and T Hayashi, and Y Koshino, and Y Kutsumi, and T Nakai, and S Miyabo
November 1991, European journal of pharmacology,
H Kato, and T Hayashi, and Y Koshino, and Y Kutsumi, and T Nakai, and S Miyabo
March 1989, The Journal of biological chemistry,
H Kato, and T Hayashi, and Y Koshino, and Y Kutsumi, and T Nakai, and S Miyabo
April 1993, The American journal of physiology,
H Kato, and T Hayashi, and Y Koshino, and Y Kutsumi, and T Nakai, and S Miyabo
February 1988, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!